Clinical Trials Browser

Phase 1/2 × INDUSTRY × trans-sodium crocetinate × Clear all

NCT01465347 2017-07-14

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Phase 1/2 Completed

59 enrolled 10 charts

Brain Neoplasms, Glioblastoma, Glioma